Anbio Biotechnology (NNNN)
Anbio Biotechnology Market Cap : 208.92M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 202.78M |
| October 07, 2026 | 215.07M |
| October 06, 2026 | 215.07M |
| October 05, 2026 | 211.99M |
| October 02, 2026 | 243.60M |
| October 01, 2026 | 276.08M |
| September 30, 2026 | 276.51M |
| September 29, 2026 | 270.37M |
| September 28, 2026 | 267.30M |
| September 25, 2026 | 276.51M |
| September 24, 2026 | 269.93M |
| September 23, 2026 | 265.98M |
| September 22, 2026 | 244.91M |
| September 21, 2026 | 249.30M |
| September 18, 2026 | 230.43M |
| September 17, 2026 | 245.79M |
| September 16, 2026 | 244.91M |
| September 15, 2026 | 241.84M |
| September 14, 2026 | 268.18M |
| September 11, 2026 | 278.27M |
| September 10, 2026 | 285.73M |
| September 09, 2026 | 283.98M |
| September 08, 2026 | 284.42M |
| September 04, 2026 | 287.05M |
| September 03, 2026 | 289.68M |
| Date | Value |
|---|---|
| September 02, 2026 | 300.65M |
| September 01, 2026 | 316.89M |
| August 31, 2026 | 320.41M |
| August 28, 2026 | 336.65M |
| August 27, 2026 | 341.47M |
| August 26, 2026 | 338.84M |
| August 25, 2026 | 343.67M |
| August 24, 2026 | 346.74M |
| August 21, 2026 | 298.90M |
| August 20, 2026 | 321.72M |
| August 19, 2026 | 340.16M |
| August 18, 2026 | 366.49M |
| August 17, 2026 | 372.42M |
| August 14, 2026 | 383.61M |
| August 13, 2026 | 450.32M |
| August 12, 2026 | 434.08M |
| August 11, 2026 | 454.27M |
| August 10, 2026 | 447.25M |
| August 07, 2026 | 465.69M |
| August 06, 2026 | 427.94M |
| August 05, 2026 | 445.50M |
| August 04, 2026 | 445.50M |
| August 03, 2026 | 467.44M |
| July 31, 2026 | 434.52M |
| July 30, 2026 | 471.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CureVac NV | 1.049B |
| PAION AG | 0.0713M |
| Epigenomics AG | 1.000M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alkermes Plc | 6.809B |
Market Cap Related Metrics
| Price | 4.76 |